Literature DB >> 12640120

Commitment point during G0-->G1 that controls entry into the cell cycle.

Nicholas C Lea1, Stephen J Orr, Kai Stoeber, Gareth H Williams, Eric W-F Lam, Mohammad A A Ibrahim, Ghulam J Mufti, N Shaun B Thomas.   

Abstract

Initiation of T-lymphocyte-mediated immune responses involves two cellular processes: entry into the cell cycle (G(0)-->G(1)) for clonal proliferation and coordinated changes in surface and secreted molecules that mediate effector functions. However, a point during G(0)-->G(1) beyond which T cells are committed to enter the cell cycle has not been defined. We define here a G(0)-->G(1) commitment point that occurs 3 to 5 h after CD3 and CD28 stimulation of human CD4 or CD8 T cells. Transition through this point requires cdk6/4-cyclin D, since inhibition with TAT-p16(INK4A) during the first 3 to 5 h prevents cell cycle entry and maintains both naive and memory T cells in G(0). Transition through the G(0)-->G(1) commitment point is also necessary for T cells to increase in size, i.e., to enter the cellular growth cycle. However, transition through this point is not required for the induction of effector functions. These can be initiated while cells are maintained in G(0) with TAT-p16(INK4A). We have termed this quiescent, activated state G(0(A)). Our data provide proof of the principle that entry of T cells into the cell cycle and cellular growth cycles are coupled at the G(0)-->G(1) commitment point but that these processes can be uncoupled from the early expression of molecules of effector functions.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12640120      PMCID: PMC150729          DOI: 10.1128/MCB.23.7.2351-2361.2003

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  59 in total

1.  Analysis of Cdc6 function in the assembly of mammalian prereplication complexes.

Authors:  Jeanette Gowen Cook; Chi-Hyun Park; Thomas W Burke; Gustavo Leone; James DeGregori; Amber Engel; Joseph R Nevins
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

2.  A critical role for Dnmt1 and DNA methylation in T cell development, function, and survival.

Authors:  P P Lee; D R Fitzpatrick; C Beard; H K Jessup; S Lehar; K W Makar; M Pérez-Melgosa; M T Sweetser; M S Schlissel; S Nguyen; S R Cherry; J H Tsai; S M Tucker; W M Weaver; A Kelso; R Jaenisch; C B Wilson
Journal:  Immunity       Date:  2001-11       Impact factor: 31.745

Review 3.  G1 events and regulation of cell proliferation.

Authors:  A B Pardee
Journal:  Science       Date:  1989-11-03       Impact factor: 47.728

4.  CD28 costimulation mediates down-regulation of p27kip1 and cell cycle progression by activation of the PI3K/PKB signaling pathway in primary human T cells.

Authors:  Leonard J Appleman; Andre A F L van Puijenbroek; Kirstin M Shu; Lee M Nadler; Vassiliki A Boussiotis
Journal:  J Immunol       Date:  2002-03-15       Impact factor: 5.422

5.  New cell cycle compartments identified by multiparameter flow cytometry.

Authors:  Z Darzynkiewicz; F Traganos; M R Melamed
Journal:  Cytometry       Date:  1980-09

6.  Microenvironment produced by acute myeloid leukemia cells prevents T cell activation and proliferation by inhibition of NF-kappaB, c-Myc, and pRb pathways.

Authors:  A G Buggins; D Milojkovic; M J Arno; N C Lea; G J Mufti; N S Thomas; W J Hirst
Journal:  J Immunol       Date:  2001-11-15       Impact factor: 5.422

7.  RB activation defect in tumor cell lines.

Authors:  Cristina Broceño; Scott Wilkie; Sibylle Mittnacht
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-11       Impact factor: 11.205

8.  Serial triggering of T cell receptors results in incremental accumulation of signaling intermediates.

Authors:  Zipora Borovsky; Galit Mishan-Eisenberg; Einat Yaniv; Jacob Rachmilewitz
Journal:  J Biol Chem       Date:  2002-04-08       Impact factor: 5.157

9.  Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins.

Authors:  T R Mosmann; H Cherwinski; M W Bond; M A Giedlin; R L Coffman
Journal:  J Immunol       Date:  1986-04-01       Impact factor: 5.422

10.  Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E.

Authors:  Diane C Fingar; Sofie Salama; Christina Tsou; Ed Harlow; John Blenis
Journal:  Genes Dev       Date:  2002-06-15       Impact factor: 11.361

View more
  32 in total

1.  Reducing MCM levels in human primary T cells during the G(0)-->G(1) transition causes genomic instability during the first cell cycle.

Authors:  S J Orr; T Gaymes; D Ladon; C Chronis; B Czepulkowski; R Wang; G J Mufti; E M Marcotte; N S B Thomas
Journal:  Oncogene       Date:  2010-05-03       Impact factor: 9.867

2.  Cyclin-C-dependent cell-cycle entry is required for activation of non-homologous end joining DNA repair in postmitotic neurons.

Authors:  A Tomashevski; D R Webster; P Grammas; M Gorospe; I I Kruman
Journal:  Cell Death Differ       Date:  2010-01-29       Impact factor: 15.828

3.  Activation of postnatal neural stem cells requires nuclear receptor TLX.

Authors:  Wenze Niu; Yuhua Zou; Chengcheng Shen; Chun-Li Zhang
Journal:  J Neurosci       Date:  2011-09-28       Impact factor: 6.167

4.  Cell cycle phase distribution analysis in chronic lymphocytic leukaemia: a significant number of cells reside in early G1-phase.

Authors:  Ellen C Obermann; Philip Went; Alexandar Tzankov; Stefano A Pileri; Ferdinand Hofstaedter; Joerg Marienhagen; Robert Stoehr; Stephan Dirnhofer
Journal:  J Clin Pathol       Date:  2006-09-01       Impact factor: 3.411

5.  Epigenetics of human T cells during the G0-->G1 transition.

Authors:  Alexander E Smith; Constantinos Chronis; Manolis Christodoulakis; Stephen J Orr; Nicholas C Lea; Natalie A Twine; Akshay Bhinge; Ghulam J Mufti; N Shaun B Thomas
Journal:  Genome Res       Date:  2009-06-22       Impact factor: 9.043

Review 6.  Immune suppressive properties of artemisinin family drugs.

Authors:  Lifei Hou; Haochu Huang
Journal:  Pharmacol Ther       Date:  2016-07-10       Impact factor: 12.310

7.  T cell exit from quiescence and differentiation into Th2 cells depend on Raptor-mTORC1-mediated metabolic reprogramming.

Authors:  Kai Yang; Sharad Shrestha; Hu Zeng; Peer W F Karmaus; Geoffrey Neale; Peter Vogel; David A Guertin; Richard F Lamb; Hongbo Chi
Journal:  Immunity       Date:  2013-12-05       Impact factor: 31.745

Review 8.  Coley's immunotherapy revived: Innate immunity as a link in priming cancer cells for an attack by adaptive immunity.

Authors:  Ondrej Uher; Veronika Caisova; Per Hansen; Jan Kopecky; Jindrich Chmelar; Zhengping Zhuang; Jan Zenka; Karel Pacak
Journal:  Semin Oncol       Date:  2019-11-06       Impact factor: 4.929

9.  JAK3/STAT5/6 pathway alterations are associated with immune deviation in CD8 T cells in renal cell carcinoma patients.

Authors:  Elisabetta Cavalcanti; Margherita Gigante; Vito Mancini; Michele Battaglia; Pasquale Ditonno; Carmela Capobianco; Raffaele I Cincione; Francesco P Selvaggi; Wolfgang Herr; Walter J Storkus; Loreto Gesualdo; Elena Ranieri
Journal:  J Biomed Biotechnol       Date:  2010-03-22

Review 10.  Age-associated changes in immune and inflammatory responses: impact of vitamin E intervention.

Authors:  Dayong Wu; Simin Nikbin Meydani
Journal:  J Leukoc Biol       Date:  2008-07-02       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.